ID PGDS_HUMAN STANDARD; PRT; 1089 AA. AC P16234; DT 01-APR-1990 (Rel. 14, Created) DT 01-APR-1990 (Rel. 14, Last sequence update) DT 20-AUG-2001 (Rel. 40, Last annotation update) DE ALPHA PLATELET-DERIVED GROWTH FACTOR RECEPTOR PRECURSOR (EC 2.7.1.112) DE (PDGF-R-ALPHA) (CD140A ANTIGEN). GN PDGFRA. OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP SEQUENCE FROM N.A. RX MEDLINE=89130149; PubMed=2536956; RA Matsui T., Heidaran M., Miki T., Popescu N., la Rochelle W., RA Kraus M., Pierce J., Aaronson S.; RT "Isolation of a novel receptor cDNA establishes the existence of two RT PDGF receptor genes."; RL Science 243:800-804(1989). RN [2] RP SEQUENCE FROM N.A. RX MEDLINE=89296915; PubMed=2544881; RA Claesson-Welsh L., Eriksson A., Westermark B., Heldin C.H.; RT "cDNA cloning and expression of the human A-type platelet-derived RT growth factor (PDGF) receptor establishes structural similarity to RT the B-type PDGF receptor."; RL Proc. Natl. Acad. Sci. U.S.A. 86:4917-4921(1989). CC -!- FUNCTION: THIS RECEPTOR BINDS PLATELET-DERIVED GROWTH FACTOR AND CC HAS A TYROSINE-PROTEIN KINASE ACTIVITY. THIS RECEPTOR CAN BIND CC EITHER PDGF-A OR PDGF-B. CC -!- CATALYTIC ACTIVITY: ATP + A PROTEIN TYROSINE = ADP + PROTEIN CC TYROSINE PHOSPHATE. CC -!- SUBUNIT: DIMER OF EITHER ALPHA-ALPHA, BETA-BETA OR ALPHA-BETA CC SUBUNITS. CC -!- SUBCELLULAR LOCATION: TYPE I MEMBRANE PROTEIN. CC -!- SIMILARITY: BELONGS TO THE CSF-1/PDGF RECEPTOR FAMILY OF TYROSINE- CC PROTEIN KINASES. CC -!- SIMILARITY: CONTAINS 5 IMMUNOGLOBULIN-LIKE C2-TYPE DOMAINS. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M21574; AAA96715.1; -. DR EMBL; M22734; AAA60048.1; -. DR PIR; A40162; PFHUGA. DR HSSP; P11362; 1AGW. DR MIM; 173490; -. DR InterPro; IPR000719; Euk_pkinase. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR003598; Ig_c2. DR InterPro; IPR003600; Ig_like. DR InterPro; IPR001824; Rcptor_tyr_kin_III. DR InterPro; IPR001245; Tyr_kin. DR Pfam; PF00047; ig; 3. DR Pfam; PF00069; pkinase; 2. DR SMART; SM00408; IGc2; 1. DR SMART; SM00410; IG_like; 2. DR SMART; SM00219; TyrKc; 1. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS00109; PROTEIN_KINASE_TYR; 1. DR PROSITE; PS00240; RECEPTOR_TYR_KIN_III; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. KW Tyrosine-protein kinase; Receptor; Transmembrane; Glycoprotein; KW Transferase; Phosphorylation; ATP-binding; Immunoglobulin domain; KW Signal. FT SIGNAL 1 23 FT CHAIN 24 1089 ALPHA PLATELET-DERIVED GROWTH FACTOR FT RECEPTOR. FT DOMAIN 24 524 EXTRACELLULAR (POTENTIAL). FT TRANSMEM 525 549 POTENTIAL. FT DOMAIN 550 1089 CYTOPLASMIC (POTENTIAL). FT DOMAIN 593 954 PROTEIN KINASE. FT DOMAIN 1041 1087 SER-RICH. FT NP_BIND 599 607 ATP (BY SIMILARITY). FT BINDING 627 627 ATP (BY SIMILARITY). FT ACT_SITE 818 818 BY SIMILARITY. FT MOD_RES 849 849 PHOSPHORYLATION (AUTO-) (BY SIMILARITY). FT CARBOHYD 42 42 N-LINKED (GLCNAC...) (POTENTIAL). FT CARBOHYD 76 76 N-LINKED (GLCNAC...) (POTENTIAL). FT CARBOHYD 103 103 N-LINKED (GLCNAC...) (POTENTIAL). FT CARBOHYD 179 179 N-LINKED (GLCNAC...) (POTENTIAL). FT CARBOHYD 353 353 N-LINKED (GLCNAC...) (POTENTIAL). FT CARBOHYD 359 359 N-LINKED (GLCNAC...) (POTENTIAL). FT CARBOHYD 458 458 N-LINKED (GLCNAC...) (POTENTIAL). FT CARBOHYD 468 468 N-LINKED (GLCNAC...) (POTENTIAL). SQ SEQUENCE 1089 AA; 122669 MW; 5E3FB9940ACD1BE8 CRC64; MGTSHPAFLV LGCLLTGLSL ILCQLSLPSI LPNENEKVVQ LNSSFSLRCF GESEVSWQYP MSEEESSDVE IRNEENNSGL FVTVLEVSSA SAAHTGLYTC YYNHTQTEEN ELEGRHIYIY VPDPDVAFVP LGMTDYLVIV EDDDSAIIPC RTTDPETPVT LHNSEGVVPA SYDSRQGFNG TFTVGPYICE ATVKGKKFQT IPFNVYALKA TSELDLEMEA LKTVYKSGET IVVTCAVFNN EVVDLQWTYP GEVKGKGITM LEEIKVPSIK LVYTLTVPEA TVKDSGDYEC AARQATREVK EMKKVTISVH EKGFIEIKPT FSQLEAVNLH EVKHFVVEVR AYPPPRISWL KNNLTLIENL TEITTDVEKI QEIRYRSKLK LIRAKEEDSG HYTIVAQNED AVKSYTFELL TQVPSSILDL VDDHHGSTGG QTVRCTAEGT PLPDIEWMIC KDIKKCNNET SWTILANNVS NIITEIHSRD RSTVEGRVTF AKVEETIAVR CLAKNLLGAE NRELKLVAPT LRSELTVAAA VLVLLVIVII SLIVLVVIWK QKPRYEIRWR VIESISPDGH EYIYVDPMQL PYDSRWEFPR DGLVLGRVLG SGAFGKVVEG TAYGLSRSQP VMKVAVKMLK PTARSSEKQA LMSELKIMTH LGPHLNIVNL LGACTKSGPI YIITEYCFYG DLVNYLHKNR DSFLSHHPEK PKKELDIFGL NPADESTRSY VILSFENNGD YMDMKQADTT QYVPMLERKE VSKYSDIQRS LYDRPASYKK KSMLDSEVKN LLSDDNSEGL TLLDLLSFTY QVARGMEFLA SKNCVHRDLA ARNVLLAQGK IVKICDFGLA RDIMHDSNYV SKGSTFLPVK WMAPESIFDN LYTTLSDVWS YGILLWEIFS LGGTPYPGMM VDSTFYNKIK SGYRMAKPDH ATSEVYEIMV KCWNSEPEKR PSFYHLSEIV ENLLPGQYKK SYEKIHLDFL KSDHPAVARM RVDSDNAYIG VTYKNEEDKL KDWEGGLDEQ RLSADSGYII PLPDIDPVPE EEDLGKRNRH SSQTSEESAI ETGSSSSTFI KREDETIEDI DMMDDIGIDS SDLVEDSFL //